Gramicidin, Neomycin, Polymyxin b

Odan-Spor

.025 MG / ML + 1.75 MG / ML + 10000 UNIT / ML LiquidCanadaNot marketedAuthorised 31 Dec 1992

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Neomycin and Polymyxin B Sulfates and GramicidinUnited States · 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML · solution/drops · Watson LabsSame strength and form
Neo-PolycinUnited States · 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML · solution/drops · Dow PharmSame strength and form
Neomycin Sulfate and Polymyxin B Sulfate GramicidinUnited States · 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML · solution/drops · PharmafairSame strength and form
Oftalmowell Colirio en SoluciónSpain · 25 UI + 1700 UI + 5000 UI · colirio en solución · Teofarma S.R.L.Same substance
Polyspectran Eye Ear DropsSaudi Arabia · DR. Thilo LaboratoriesSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Gramicidin, Neomycin, Polymyxin b

Odan-Spor

.025 MG / ML + 1.75 MG / ML + 10000 UNIT / ML LiquidCanadaNot marketedAuthorised 31 Dec 1992

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Gramicidin, Neomycin, Polymyxin b
Strength: .025 MG / ML + 1.75 MG / ML + 10000 UNIT / ML
Dosage form: Liquid
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Not marketed
Status in the register: Dormant
Authorised: 31 Dec 1992
Registration: DIN 00635065
Marketing authorisation holder: Odan Laboratoriesltd
ATC code: S01AA30
Group: Sensory organs
Supply: PRESCRIPTION

Canada

Cancelled

Optimyxin PlusGramicidin + Neomycin + Polymyxin b · 0.025 MG / ML + 1.75 MG / ML + 10000 UNIT / ML · SolutionCanadaCancelled